Xin-Li-Fang efficacy and safety for patients with chronic heart failure: A study protocol for a randomized, double-blind, and placebo-controlled trial

INTRODUCTION: Xin-Li-Fang (XLF), a representative Chinese patent medicine, was derived from years of clinical experience by academician Chen Keji, and is widely used to treat chronic heart failure (CHF). However, there remains a lack of high-quality evidence to support clinical decision-making. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tong, Yao, Sijie, Jiang, Wei, Lan, Taohua, Xu, Wenjing, Cao, Haiming, Yao, Ping, Wang, Chao, Lu, Weihui, Chen, Xiankun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911457/
https://www.ncbi.nlm.nih.gov/pubmed/36776264
http://dx.doi.org/10.3389/fcvm.2023.1103548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911457/
https://www.ncbi.nlm.nih.gov/pubmed/36776264
http://dx.doi.org/10.3389/fcvm.2023.1103548

Ejemplares similares